Company Name, Ticker, Customers, else..

Precipio inc (PRPO)

Other Ticker:

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

PRPO's Revenue Growth by Quarter and Year

Precipio Inc 's Revenue results by quarter and year

Select the Comparisons :

None ▼

Select the Ratio:

Revenue Growth Y/Y▼

None ▼

Revenue Growth Y/Y▼

PRPO Revenue (in millions $)		FY 2022	FY 2021	FY 2020	FY 2019
IV Quarter	December	-	2.44	1.94	0.69
III Quarter	September	2.22	2.25	1.63	0.78
II Quarter	June	2.36	2.34	1.31	0.94
I Quarter	March	2.45	1.82	1.22	0.71
FY		7.03	8.85	6.10	3.12

PRPO Revenue third quarter 2022 Y/Y Growth Comment

Precipio Inc reported decrease in Revenue in the third quarter 2022 by -1.56% to $ 2.22 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 Precipio Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 3.6%.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 76 other companies have achieved higher Revenue growth. While Precipio Inc ' s Revenue decline of -1.56% ranks overall at the positon no. 2091 in the third quarter 2022.

PRPO Revenue ( Y/Y Growth %)		2022	2021	2020	2019
IV Quarter	December	-	25.77 %	181.16 %	-54.3 %
III Quarter	September	-1.56 %	38.04 %	108.97 %	9.86 %
II Quarter	June	0.85 %	78.63 %	39.36 %	123.81 %
I Quarter	March	34.62 %	49.18 %	71.83 %	115.15 %
FY		-	45.08 %	95.51 %	5.05 %

Financial Statements
Precipio Inc 's third quarter 2022 Revenue	$ 2.22 millions	PRPO's Income Statement
Precipio Inc 's third quarter 2021 Revenue	$ 2.25 millions	Quarterly PRPO's Income Statement
New: More PRPO's historic Revenue Growth >>

PRPO Revenue (Quarter on Quarter Growth %)		2022	2021	2020	2019
IV Quarter	December	-	8.44 %	19.02 %	-11.54 %
III Quarter	September	-6.14 %	-3.85 %	24.43 %	-17.02 %
II Quarter	June	-3.67 %	28.57 %	7.38 %	32.39 %
I Quarter	March	0.41 %	-6.19 %	76.81 %	-52.98 %
FY (Year on Year)		-	45.08 %	95.51 %	5.05 %

Explore PRPO Customer Growth by Product and Service >> Back to PRPO Growth rate Comparisons >>

Revenue third quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#77
Healthcare Sector	#318
Overall	#2091

Revenue Y/Y Growth Statistics
High	Average	Low
67.14 %	3.6 %	-93.44 %
(Dec 31 2018)		(Dec 31 2015)

Revenue third quarter 2022 Y/Y Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#77
Healthcare Sector	#318
Overall	#2091

Revenue Y/Y Growth Statistics
High	Average	Low
67.14 %	3.6 %	-93.44 %
(Dec 31 2018)		(Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Precipio Inc 's Q/Q Revenue Growth

Revenue Q/Q Growth Statistics
High	Average	Low
113.98 %	7.41 %	-52.75 %
(Jun 30 2016)

PRPO's III. Quarter Q/Q Revenue Comment

In the III. Quarter 2022 Precipio Inc reported decline in Revenue from the previous quarter by -6.14% to $ 2.22 millions, from $ 2.36 millions released a quarter before.

But that's not important concern, as Precipio Inc 's Revenue always gravitate to dip in this quarter Melissa Miller, Healthcare sector researcher told.

Within Biotechnology & Pharmaceuticals industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2258.

Revenue Q/Q Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#85
Healthcare Sector	#369
Overall	#2258

Revenue Q/Q Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#85
Healthcare Sector	#369
Overall	#2258

Revenue Q/Q Growth Statistics
High	Average	Low
113.98 %	7.41 %	-52.75 %
(Jun 30 2016)

PRPO's III. Quarter Q/Q Revenue Comment

In the III. Quarter 2022 Precipio Inc reported decline in Revenue from the previous quarter by -6.14% to $ 2.22 millions, from $ 2.36 millions achived a quarter before.

It's not huge concern, as Revenue frequently gravitate to dip in this quarter Melissa Miller, Healthcare sector researcher told.

Within Biotechnology & Pharmaceuticals industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2258.

Precipio Inc 's 12 Months Revenue Growth Year on Year

Revenue TTM Growth	12 Months Ending (Sep 30 2022)	12 Months Ending (Jun 30 2022)	12 Months Ending (Mar 31 2022)	12 Months Ending (Dec 31 2021)	12 Months Ending (Sep 30 2021)
Cumulative Revenue 12 Months Ending	$ 9.46	$ 9.49	$ 9.47	$ 8.85	$ 8.36
Y / Y Revenue Growth (TTM)	13.18 %	22.63 %	41.37 %	45.26 %	72.66 %
Year on Year Revenue Growth Overall Ranking	# 1239	# 973	# 670	# 647	# 417
Seqeuential Revenue Change (TTM)	-0.33 %	0.16 %	7.04 %	5.91 %	8 %
Seq. Revenue Growth (TTM) Overall Ranking	# 2091	# 2163	# 743	# 1275	# 1086

New: More PRPO's historic Revenue Growth >>

Cumulative Revenue growth Comment

With the quarterly Revenue reported in the Sep 30 2022 period, Precipio Inc 's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of 8% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Precipio Inc 's Revenue growth from the 2.36% growth in Jun 30 2022.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 973 to 1239.

Revenue TTM Q/Q Growth Statistics
High	Average	Low
67.14 %	3.6 %	-93.44 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 77
Healthcare Sector	# 193
Overall	# 1239

Revenue TTM Y/Y Growth Statistics
High	Average	Low
124.96 %	27.76 %	-93.9 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 77
Sector	# 318
S&P 500	# 2091

Cumulative Revenue growth Comment

With the quarterly Revenue reported in the Sep 30 2022 period, Precipio Inc 's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of -93.9% year on year, if the fiscal year would end at Sep 30 2022.
A slow-down in the Precipio Inc 's Revenue growth from the 2.36% growth in Jun 30 2022.

In the Healthcare sector 192 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 973 to 1239.

Revenue TTM Q/Q Growth Statistics
High	Average	Low
67.14 %	3.6 %	-93.44 %

Revenue TTM Y/Y Growth Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 77
Healthcare Sector	# 193
Overall	# 1239

Revenue TTM Y/Y Growth Statistics
High	Average	Low
124.96 %	27.76 %	-93.9 %

Revenue TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 77
Sector	# 318
S&P 500	# 2091

Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRPO's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PRPO's Competitors
Revenue Growth for Precipio Inc 's Suppliers
Revenue Growth for PRPO's Customers

You may also want to know
PRPO's Annual Growth Rates	PRPO's Profitability Ratios	PRPO's Asset Turnover Ratio	PRPO's Dividend Growth
PRPO's Roe	PRPO's Valuation Ratios	PRPO's Financial Strength Ratios	PRPO's Dividend Payout Ratio
PRPO's Roa	PRPO's Inventory Turnover Ratio	PRPO's Growth Rates	PRPO's Dividend Comparisons

Companies with similar Revenue decline for the quarter ending Sep 30 2022 within Healthcare Sector	Y/Y Change %	Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc	-0.19%	$ -0.191 millions
National Research Corporation	-0.20%	$ -0.201 millions
Livanova Plc	-0.24%	$ -0.241 millions
Healthcare Services Group Inc	-0.27%	$ -0.265 millions
Catalent Inc	-0.29%	$ -0.293 millions
Asensus Surgical Inc	-0.31%	$ -0.311 millions
Liquidia Corporation	-0.43%	$ -0.429 millions
Integra Lifesciences Holdings Corp	-0.43%	$ -0.432 millions
Pediatrix Medical Group Inc	-0.62%	$ -0.615 millions
China Pharma Holdings Inc	-0.64%	$ -0.642 millions
Acadia Pharmaceuticals Inc	-0.68%	$ -0.682 millions
Syneos Health Inc	-0.89%	$ -0.891 millions
Innovage Holding Corp	-1.07%	$ -1.070 millions
Procyon Corp	-1.20%	$ -1.200 millions
Precipio inc	-1.38%	$ -1.380 millions
Ati Physical Therapy Inc	-1.40%	$ -1.397 millions
Ocular Therapeutix Inc	-1.55%	$ -1.547 millions
Alpine Immune Sciences Inc	-1.75%	$ -1.750 millions
Surgalign Holdings Inc	-1.79%	$ -1.786 millions
Tenet Healthcare Corp	-1.90%	$ -1.900 millions
Teleflex Incorporated	-1.92%	$ -1.923 millions
Novocure Limited	-1.95%	$ -1.952 millions
Dynatronics Corporation	-2.01%	$ -2.014 millions
Royalty Pharma Plc	-2.10%	$ -2.101 millions
National Healthcare Corp	-2.13%	$ -2.130 millions
Fonar Corporation	-2.27%	$ -2.271 millions
Psychemedics Corp	-2.35%	$ -2.353 millions
Escalon Medical Corp	-2.63%	$ -2.626 millions
Lifevantage Corp	-2.72%	$ -2.724 millions
West Pharmaceutical Services Inc	-2.77%	$ -2.774 millions


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar ADMEN's Profile Stock Price ADMEN's Financials Business Description Fundamentals Charts & Quotes ADMEN's News Suppliers ADMEN's Competitors Customers & Markets Economic Indicators ADMEN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

PRPO's Revenue Growth by Quarter and Year

PRPO Revenue (Quarter on Quarter Growth %)

Revenue TTM Growth